biopharmaceutical company
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, education around COVID-19 therapies, and PDUFA Reauthorization. S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act (draft legislation). General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376). H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); all bio-pharmaceutical related provisions. Implementation of Tax Cuts and Jobs Act (P.L.115-97). FY2022 Budget Reconciliation (H.R.5376); issues related to international taxation. Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues. Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021; H.R.4521, America COMPETES Act of 2022. Issues related to WTO TRIPS Waiver Process.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign)
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN BRITTANY JOHNSON HERNANDEZ